Suomen Terveystalo Oyj's share subscription price EUR 2.40 in the institution and public issue and EUR 2.16 in personnel issue

Suomen Terveystalo Oyj 	Stock Exchange Release	 2 April 2007, 1:15 pm

Not to be published or distributed in the United States, Canada, Australia or
Japan. 


The Board of Directors of Suomen Terveystalo Oyj (”Suomen Terveystalo” or ”the
Company”) has decided to carry out a share issue, in which a total of
20,000,000 new shares will be subscribed. The board's decision is based on the
share issue authorization given to the Board of Directors by the Company's
extraordinary general meeting on November 7, 2006 and the board's decision on
issuing a maximum of 20,000,000 new shares on the basis of this authorization
as of March 15, 2007. The shares to be subscribed in the share issue correspond
to approximately 29.8 percent of the Company's number of shares after the share
issue. In addition, there will be an extra allocation of 1,085,133 shares for
investors. Taking the extra allocation into account, the shares allocated in
the share issue will correspond to a total of 31.4 percent of the Company's
shares after the share issue. 

The Company's Board of Directors has decided that the share subscription price
is EUR 2.40 per share in the institution issue and EUR 2.16 per share in the
public and personnel issue. For Suomen Terveystalo, the gross income from the
issue of the new shares will be approximately EUR 47.9 million and the earnings
will be approximately EUR 46.6 million after the deduction of the organizers'
fees. Suomen Terveystalo will use the assets acquired through the share issue
to carry out its business development and growth strategy. 

The preliminary offering to institutional investors was 15,650,000 shares -
4,000,000 shares to public investors and 350,000 shares to the personnel. At
the board meeting on April 2, 2007, the Board of Directors of Suomen
Terveystalo decided that the size of the institutional issue will be 15,130,200
shares, the public issue will be 4,569,500 shares and the personnel issue will
be 300,300 shares. The institutional issue provided subscription offers for
16,215,333 shares with the fixed subscription price; this exceeds the final
size of the institutional issue by 1,085,133 shares. Approximately 69.5 percent
of the demand for the institutional issue came from Finnish investors and
approximately 30.5 percent from international investors. The public issue
provided subscription commitments for 4,569,500 shares and the personnel issue
for 300,300 shares. 3,612 investors took part in the public issue and 191
investors in the personnel issue. 

Those who took part in the public and personnel issue will receive all of the
subscribed shares.  The extra subscription payments will be returned to
investors on April 10, 2007. All shares approved as subscribed and paid in full
in the public issue and personnel issue will be registered in the investors'
book-entry accounts on April 3, 2007. A confirmation of all approved
subscription commitments will be sent to the investors taking part in the
public issue and personnel issue on April 12, 2007. 

The quotation of Suomen Terveystalo's shares will begin in the Pre-list of the
Helsinki Stock Exchange on April 3, 2007 and in the Official list on April 10,
2007. 

Suomen Terveystalo Oyj
Martti Kiuru
CEO
 
More information:
Suomen Terveystalo Oyj, CEO Martti Kiuru, tel. +358 9 2310 6100
Suomen Terveystalo Oyj, CFO Timo Leinonen, tel. +358 400 793 073


The information contained in this release is not intended to be published or
released in Australia, Canada, Japan or the United States. This release is not
an offer for share subscription or sales in the United States, and the shares
cannot be offered or sold in the United States without registration or
otherwise, apart from irregular cases concerning the registration obligation
that are allowed according to the Securities Act 1933, its amendments and the
related rules and regulations. This share issue/offering or any of its parts
will not be registered in the United States and the shares will not be sold
publicly in the United States. 

This release is not a direct or an indirect offer concerning possible share
sales or acquisitions, and the shares will not be sold in areas where the
offering or sales of these shares would be illegal before the registration of
the shares or deviate from the registration obligation or any other approval in
accordance with the securities law in the concerned areas. 

This document is not an offer to sell securities to the public in Great
Britain. The listing prospectus concerning securities has not been and will not
be registered in Great Britain; thus the share issue is only directed to people
who are (i) outside Great Britain or (ii) who fall within the Financial
Services and Markets Act 2000 of Great Britain and its regulation of 2005
(Financial Promotion) and article 19(5) (investment professionals) (”Concerned
People”). Those who are not Concerned People cannot operate on the basis of
this release or base their operations on this release. 

Stabilization/FSA